France · 
Who invested in Tafalgie Therapeutics?
Tafalgie Therapeutics's investors include Bpifrance and EIC Accelerator.
France · Series A startup
Who invested in Tafalgie Therapeutics
Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $14MSept 2025
- Investors
- 2
The rounds
- Sept 2025
Founders and team
From Tafalgie Therapeutics's own website: 1 founder, 19 on the team.
- Eric SchettiniPresident of the Executive board and CEO
- Nadia MalliouPresident of Pain Alliance Europe Greece
- Aziz MoqrichVP and Chief Scientific Officer (CSO)
- Laetitia LyscarHead of Clinical Affairs
- Manon BohicHead of Research and Development Projects
- Adja Fatou DiackWork-Training Quality Assurance Manager
- Alexandre DesfouxProject Manager
- Aude CharronResearch Engineer
- Aurelie MorinSenior Clinical and Translational Project Manager
- Caroline MathonExecutive Director General Councel
- Catarina SantosSenior Preclinical Research Manager
- Isabelle MoqrichExecutive Assistant and Office Manager
- Joanie Del BanoExecutive Director of clinical development and regulatory affairs
- Laure Lo RéR&D Project Manager
- Luc RiolsCoporate project manager
- Mathilde CaraglioRegulatory Affairs Intern
- Mathilde SchettiniArtistic Officer
- Nafisatou DrameStudy engineer
And 1 more on the team.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tafalgie Therapeutics
How much has Tafalgie Therapeutics raised?
Tafalgie Therapeutics has raised $14M across 1 round since 2025.
When did Tafalgie Therapeutics last raise?
Tafalgie Therapeutics's most recent round was a Series A of $14M in Sept 2025.
What was Tafalgie Therapeutics's biggest round?
Its most recent round, $14M in Sept 2025, is also its largest on record.
Who backed Tafalgie Therapeutics first?
Tafalgie Therapeutics's first round on record, in Sept 2025, was backed by Bpifrance and EIC Accelerator.
What stage is Tafalgie Therapeutics at?
Tafalgie Therapeutics's latest named round is a Series A, in Sept 2025.
Where is Tafalgie Therapeutics based?
Tafalgie Therapeutics is based in France.
Companies like Tafalgie Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.